Monthly Archives: April 2019

CME Exam 3: Real-time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations that Might be Targeted with Existing Drugs or Used as Biomarkers

Posted in News | Comments Off on CME Exam 3: Real-time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations that Might be Targeted with Existing Drugs or Used as Biomarkers

CME Exam 1: Zenker’s Diverticulum Per-Oral Endoscopic Myotomy Techniques: Changing Paradigms

Posted in News | Comments Off on CME Exam 1: Zenker’s Diverticulum Per-Oral Endoscopic Myotomy Techniques: Changing Paradigms

CME Exam 2: Events Within the First Year of Life, But Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases

Posted in News | Comments Off on CME Exam 2: Events Within the First Year of Life, But Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases

Reply

We thank Rayar et al and Moro et al, for their interest in our recent publication1 and for highlighting some challenging issues regarding primary biliary cholangitis (PBC) recurrence after liver transplantation (LT). Continue reading

Posted in News | Comments Off on Reply

Depression, Antidepressants, and Inflammatory Bowel Disease: Implications for Future Models of Care

Frolkis AD, Vallerand IA, Shaheen A-A, et al. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut 2018;doi:10.1136/gutjnl-2018-317182 Continue reading

Posted in News | Comments Off on Depression, Antidepressants, and Inflammatory Bowel Disease: Implications for Future Models of Care

Noninvasively Predicting Hemodynamic Response to Carvedilol in Cirrhotic Patients with Varices: You Have Some Ex-Spleening to Do

Kim HY, So YH, Kim W, et al. Noninvasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. J Hepatol 2019;70:412–422. Continue reading

Posted in News | Comments Off on Noninvasively Predicting Hemodynamic Response to Carvedilol in Cirrhotic Patients with Varices: You Have Some Ex-Spleening to Do

Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk

Chronic hepatitis C virus (HCV) infections affect an estimated 71 million individuals worldwide. The virus establishes persistence in about 70% of cases and, in the majority, infections remain asymptomatic. However, persistent HCV infection causes prof… Continue reading

Posted in News | Comments Off on Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk

Effectiveness of Infliximab Biosimilar in Crohn’s Disease: A Dime, A Dozen

Meyer A, Rudant J, Drouin J, et al. Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a French equivalence study. Ann Intern Med 2019;170:99–107. Continue reading

Posted in News | Comments Off on Effectiveness of Infliximab Biosimilar in Crohn’s Disease: A Dime, A Dozen

Confirming Complexity: Assessing Environmental and Genetic Risk Factors for Inflammatory Bowel Disease

The incidence of inflammatory bowel disease (IBD) is increasing worldwide with the highest incidence rates in westernized countries such as those of northern Europe, the United Kingdom, and North America. These countries share many possible environment… Continue reading

Posted in News | Comments Off on Confirming Complexity: Assessing Environmental and Genetic Risk Factors for Inflammatory Bowel Disease

The Present State and Future Direction of Regenerative Medicine for Perianal Crohn’s Disease

Perianal Crohn’s disease (CD), affecting nearly one-third of patients with CD, is a highly morbid condition owing to incontinence, perianal pain, recurrent infection, and decreased quality of life.1 Notoriously difficult to treat, patients are left c… Continue reading

Posted in News | Comments Off on The Present State and Future Direction of Regenerative Medicine for Perianal Crohn’s Disease